Adrenergic Regulation of Basal Serum Glucose, NEFA and Insulin Levels

Abstract
The effect of alpha and beta adrenergic blocking agents on the basal serum levels of glucose, NEFA and insulin was studied in normal patients. It was shown that propranolol (β-blocking agent) produced a significant decrease in each of these variables. On the other hand, the opposite effect was obtained, except for glucose, when an α-blocking agent, phentolamine, was used. These findings suggest that circulating catecholamines may regulate the above-mentioned parameters through an equilibrium between two antagonistic effects.